Synergy between PI3K signaling and MYC in Burkitt lymphomagenesis.

[1]  R. Siebert,et al.  Recurrent deletions of the TNFSF7 and TNFSF9 genes in 19p13.3 in diffuse large B‐cell and Burkitt lymphomas , 2012, International journal of cancer.

[2]  L. Staudt,et al.  Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics , 2012, Nature.

[3]  E. Jaffe,et al.  Aggressive B-cell lymphomas: a review of new and old entities in the WHO classification. , 2011, Hematology. American Society of Hematology. Education Program.

[4]  Stefano Monti,et al.  Signatures of murine B-cell development implicate Yy1 as a regulator of the germinal center-specific program , 2011, Proceedings of the National Academy of Sciences.

[5]  J. Kutok,et al.  Constitutive canonical NF-κB activation cooperates with disruption of BLIMP1 in the pathogenesis of activated B cell-like diffuse large cell lymphoma. , 2010, Cancer cell.

[6]  R. Rickert,et al.  Cyclin D3 Is Selectively Required for Proliferative Expansion of Germinal Center B Cells , 2010, Molecular and Cellular Biology.

[7]  B. Diamond,et al.  Requirement for cyclin D3 in germinal center formation and function , 2010, Cell Research.

[8]  Adam M. Gustafson,et al.  Airway PI3K Pathway Activation Is an Early and Reversible Event in Lung Cancer Development , 2010, Science Translational Medicine.

[9]  Doron Betel,et al.  Genetic dissection of the miR-17~92 cluster of microRNAs in Myc-induced B-cell lymphomas. , 2009, Genes & development.

[10]  S. Lowe,et al.  miR-19 is a key oncogenic component of mir-17-92. , 2009, Genes & development.

[11]  R. DePinho,et al.  PI3 Kinase Signals BCR-Dependent Mature B Cell Survival , 2009, Cell.

[12]  Jürgen Läuter,et al.  High‐dimensional data analysis: Selection of variables, data compression and graphics – Application to gene expression , 2009, Biometrical journal. Biometrische Zeitschrift.

[13]  T. Mak,et al.  PTEN Deletion and Concomitant c-Myc Activation Do Not Lead to Tumor Formation in Pancreatic β Cells* , 2009, Journal of Biological Chemistry.

[14]  R. Siebert,et al.  Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of todays knowledge , 2008, Leukemia.

[15]  J. Bishop,et al.  The B Cell Antigen Receptor and Overexpression of MYC Can Cooperate in the Genesis of B Cell Lymphomas , 2008, PLoS biology.

[16]  J. Blenis,et al.  Activation of PI3K/Akt and MAPK pathways regulates Myc-mediated transcription by phosphorylating and promoting the degradation of Mad1 , 2008, Proceedings of the National Academy of Sciences.

[17]  Terence P. Speed,et al.  Estimation and assessment of raw copy numbers at the single locus level , 2008, Bioinform..

[18]  Amit Kumar,et al.  Phosphoinositide 3-Kinase Activation in Late G1 Is Required for c-Myc Stabilization and S Phase Entry , 2006, Molecular and Cellular Biology.

[19]  K. Calame,et al.  Regulation of class-switch recombination and plasma cell differentiation by phosphatidylinositol 3-kinase signaling. , 2006, Immunity.

[20]  R. Spang,et al.  A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. , 2006, The New England journal of medicine.

[21]  Richard Simon,et al.  Molecular diagnosis of Burkitt's lymphoma. , 2006, The New England journal of medicine.

[22]  K. Rajewsky,et al.  Canonical NF-kappaB activity, dispensable for B cell development, replaces BAFF-receptor signals and promotes B cell proliferation upon activation. , 2006, Immunity.

[23]  K. Rajewsky,et al.  Tracking germinal center B cells expressing germ-line immunoglobulin gamma1 transcripts by conditional gene targeting. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Jeffrey T. Chang,et al.  Oncogenic pathway signatures in human cancers as a guide to targeted therapies , 2006, Nature.

[25]  Qiong Shen,et al.  Deregulated BCL6 expression recapitulates the pathogenesis of human diffuse large B cell lymphomas in mice. , 2005, Cancer cell.

[26]  T. Ried,et al.  Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice. , 2005, Cancer research.

[27]  M. Wigler,et al.  Circular binary segmentation for the analysis of array-based DNA copy number data. , 2004, Biostatistics.

[28]  O. Bachs,et al.  P38SAPK2 phosphorylates cyclin D3 at Thr-283 and targets it for proteasomal degradation , 2004, Oncogene.

[29]  A. Sánchez-Aguilera,et al.  Overall survival in aggressive B-cell lymphomas is dependent on the accumulation of alterations in p53, p16, and p27. , 2001, The American journal of pathology.

[30]  Chen-feng Qi,et al.  Burkitt Lymphoma in the Mouse , 2000, The Journal of experimental medicine.

[31]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[32]  K. Rajewsky,et al.  Cellular origin of human B-cell lymphomas. , 1999, The New England journal of medicine.

[33]  Carissa A. Sanchez,et al.  Evolution of neoplastic cell lineages in Barrett oesophagus , 1999, Nature Genetics.

[34]  A. Fischer,et al.  Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[35]  K. Rajewsky,et al.  Analysis of the B-cell progenitor compartment at the level of single cells , 1994, Current Biology.

[36]  K. Bhatia,et al.  The pattern of p53 mutations in Burkitt's lymphoma differs from that of solid tumors. , 1992, Cancer research.

[37]  V. Stewart,et al.  RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement , 1992, Cell.

[38]  S. Cory,et al.  Myc oncogene activation in B and T lymphoid tumours , 1985, Proceedings of the Royal Society of London. Series B. Biological Sciences.

[39]  F. Mitelman,et al.  Mitelman database of chromosome aberrations and gene fusions in cancer , 2014 .

[40]  T. Wirth,et al.  GSE17129: The IKK2/NF-kB-pathway suppresses MYC-induced lymphomagenesis , 2009 .